Sepracor to shift focus, cut 530 jobs
Firm cites need to remain competitive
Marlborough drug manufacturer Sepracor Corp., shifting its focus and streamlining its operations in a slumping economy, yesterday said it would cut 530 jobs, roughly 20 percent of its workforce. (Full article: 431 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
